---
$id: https://graph.org.ai/products/commodity/51162630
$type: Product
source: UNSPSC
code: "51162630"
title: "Meprotixol"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Meprotixol

**UNSPSC Code**: 51162630
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C19H23NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2JXZ154Z0Q, chemically known as 9h-thioxanthen-9-ol, 9-(3-(dimethylamino)propyl)-2-methoxy- but more generally known as meprotixol, which bears US NIH Compound Identifier 71195. European Medicines Agency schedules Meprotixol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08759MIG. The term MEPROTIXOL is an International Non-Proprietary Name. World Health Organization schedules meprotixol in its Anatomical Therapeutic Chemical (ATC) Classification. MEPROTIXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule meprotixol under HS 29349990 and SITC 51579. As of Q4 2014, MEPROTIXOL remains US FDA's Preferred Term for this commodity. Meprotixol bears US NLM identifiers UMLS ID C2981321 and NCI Concept Code C87660. SMILES: S1C2C(C(O)(CCCN(C)C)C3C1CCCC3)CC(OC)CC2.

